Literature DB >> 16188535

Role of depression and inflammation in incident coronary heart disease events.

Daichi Shimbo1, William Chaplin, Daniel Crossman, Donald Haas, Karina W Davidson.   

Abstract

Inflammatory biomarkers and depression have been proposed as novel coronary heart disease (CHD) risk markers. However, prospective studies have rarely assessed these 2 candidate CHD risk markers simultaneously in predicting incident CHD events. Therefore, although depression and elevated inflammatory biomarkers frequently covary, it is unclear how these risk markers relate to each other and to CHD event onset. The elucidation of these causal pathways has important clinical implications for patients who are depressed and/or have elevated inflammatory biomarkers. In this review, the publications examining the relations among depression, inflammation, and CHD events are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16188535     DOI: 10.1016/j.amjcard.2005.05.064

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  27 in total

Review 1.  Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review.

Authors:  An Pan; Qi Sun; Olivia I Okereke; Kathryn M Rexrode; Frank B Hu
Journal:  JAMA       Date:  2011-09-21       Impact factor: 56.272

2.  Depression and incident stroke in women.

Authors:  An Pan; Olivia I Okereke; Qi Sun; Giancarlo Logroscino; JoAnn E Manson; Walter C Willett; Alberto Ascherio; Frank B Hu; Kathryn M Rexrode
Journal:  Stroke       Date:  2011-08-11       Impact factor: 7.914

3.  Association between depression and inflammation--differences by race and sex: the META-Health study.

Authors:  Alanna Amyre Morris; Liping Zhao; Yusuf Ahmed; Neli Stoyanova; Christine De Staercke; William Craig Hooper; Gary Gibbons; Rebecca Din-Dzietham; Arshed Quyyumi; Viola Vaccarino
Journal:  Psychosom Med       Date:  2011-06-28       Impact factor: 4.312

Review 4.  Stroke in women - from evidence to inequalities.

Authors:  Charlotte Cordonnier; Nikola Sprigg; Else Charlotte Sandset; Aleksandra Pavlovic; Katharina S Sunnerhagen; Valeria Caso; Hanne Christensen
Journal:  Nat Rev Neurol       Date:  2017-07-21       Impact factor: 42.937

5.  Neurologic symptom severity after a recent noncardioembolic stroke and recurrent vascular risk.

Authors:  Jong-Ho Park; Bruce Ovbiagele
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-03-25       Impact factor: 2.136

6.  Use of antidepressants and the risk of cardiovascular and cerebrovascular disease: a meta-analysis of observational studies.

Authors:  A Biffi; L Scotti; G Corrao
Journal:  Eur J Clin Pharmacol       Date:  2017-01-09       Impact factor: 2.953

7.  Cardiovascular disease risk factors and psychological distress among Hispanics/Latinos: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Authors:  Sheila F Castañeda; Christina Buelna; Rebeca Espinoza Giacinto; Linda C Gallo; Daniela Sotres-Alvarez; Patricia Gonzalez; Addie L Fortmann; Sylvia Wassertheil-Smoller; Marc D Gellman; Aida L Giachello; Gregory A Talavera
Journal:  Prev Med       Date:  2016-02-26       Impact factor: 4.018

8.  Exploring the Link Between Posttraumatic Stress Disorder and inflammation-Related Medical Conditions: An Epidemiological Examination.

Authors:  Jack Tsai; Jianxun Shen
Journal:  Psychiatr Q       Date:  2017-12

9.  Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the Twins Heart Study.

Authors:  Shaoyong Su; Andrew H Miller; Harold Snieder; J Douglas Bremner; James Ritchie; Carisa Maisano; Linda Jones; Nancy V Murrah; Jack Goldberg; Viola Vaccarino
Journal:  Psychosom Med       Date:  2008-12-10       Impact factor: 4.312

Review 10.  Lipid effects of psychiatric medications.

Authors:  Junzo Watanabe; Yutaro Suzuki; Toshiyuki Someya
Journal:  Curr Atheroscler Rep       Date:  2013-01       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.